Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Embryo Stem Cell Researchers In Japan Call For Streamlined Review Process

This article was originally published in PharmAsia News

Executive Summary

A panel on embryonic stem cell research convened by Japan's Council for Science and Technology has advocated elimination of national reviews to accelerate stem cell research in the country. Currently in Japan, an embryo is considered a "life bud" by the administration and requires cautious handling. To obtain permission to conduct research, stem cell researchers must go through a two phase review - first with an ethics committee within the research facility and then a national committee review. The panel calls for a revision so the new guideline will track the International Society for Stem Cell Research, which requires review only from a research facility. (Click here for more-Japanese language



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts